Patient with decompensated hepatitis C virus–related cirrhosis delisted for liver transplantation after successful sofosbuvir‐based treatment

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-6473|21|3|408-409

ISSN： 1527-6465

Source： LIVER TRANSPLANTATION, Vol.21, Iss.3, 2015-03, pp. : 408-409

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radiofrequency Ablation as a Palliative Treatment of Primary Liver Sarcoma in an Inoperable Patient with Hepatitis C Virus-Related Cirrhosis

By  

Oncology Research and Treatment, Vol. 32, Iss. 8-9, 2009-07 ,pp. : 509-512

Karger

Access to resources Recommend Favorite

Sofosbuvir induced steven Johnson Syndrome in a patient with hepatitis C virus‐related cirrhosis

By  

Hepatology Communications, Vol. 2, Iss. 1, 2018-01 ,pp. : 16-20

John Wiley & Sons Inc

Access to resources Recommend Favorite

Steroid minimization immunosuppression protocol using basiliximab in adult living donor liver transplantation for hepatitis C virus‐related cirrhosis

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 12, 2015-12 ,pp. : 1178-1184

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lamivudine Therapy for Decompensated Liver Cirrhosis Related to Hepatitis B Virus Infection

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 388-393

Karger

Access to resources Recommend Favorite

Cost‐effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 9, 2015-09 ,pp. : 1055-1065

John Wiley & Sons Inc

Access to resources Recommend Favorite